In conclusion, our findings suggested that the lncRNA-PCAT-1 could be involved in the development and progression of ESCC, as a candidate prognostic biomarker in patients with ESCC to improve clinical management. The gene discussed is PCAT1; the disease is esophageal squamous cell carcinoma.